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Background: Community-acquired pneumonia (CAP) is a common cause of patient hospitalization and death, and its
burden on the healthcare system is increasing in aging societies. Here, we develop and internally validate risk-adjustment
models and scoring systems for predicting mortality in CAP patients to enable more precise measurements of hospital
performance.
Methods: Using a multicenter administrative claims database, we analyzed 35,297 patients hospitalized for CAP who had
been discharged between April 1, 2012 and September 30, 2013 from 303 acute care hospitals in Japan. We
developed hierarchical logistic regression models to analyze predictors of in-hospital mortality, and validated the
models using the bootstrap method. Discrimination of the models was assessed using c-statistics. Additionally,
we developed scoring systems based on predictors identified in the regression models.
Results: The 30-day in-hospital mortality rate was 5.8%. Predictors of in-hospital mortality included advanced age,
high blood urea nitrogen level or dehydration, orientation disturbance, respiratory failure, low blood pressure,
high C-reactive protein levels or high degree of pneumonic infiltration, cancer, and use of mechanical ventilation
or vasopressors. Our models showed high levels of discrimination for mortality prediction, with a c-statistic of 0.89
(95% confidence interval: 0.89-0.90) in the bootstrap-corrected model. The scoring system based on 8 selected
variables also showed good discrimination, with a c-statistic of 0.87 (95% confidence interval: 0.86-0.88).
Conclusions: Our mortality prediction models using administrative data showed good discriminatory power in
CAP patients. These risk-adjustment models may support improvements in quality of care through accurate hospital
evaluations and inter-hospital comparisons.
Keywords: Community-acquired pneumonia, Risk-adjusted mortality, Prognosis prediction model, Severity index,
Scoring system, Administrative databaseBackground
Community-acquired pneumonia (CAP) is one of the
most common infection-associated diseases, and is a
major cause of hospitalization and death. In particular,
older persons are particularly susceptible to CAP and
pneumonia-related complications [1]. Thus, improvements* Correspondence: imanaka-y@umin.net
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unless otherwise stated.to the quality and outcomes of CAP treatment would be
expected to have considerable benefits to the quality of life
in older persons [2].
Inter-hospital comparisons of the quality of care can
support the assessment and improvement of hospital
management [3]. Due to the inherent variations in patient
disease severity among hospitals, inter-hospital compari-
sons should involve the evaluation of risk-adjusted perfor-
mances that can distinguish between disease severity effects
from care effects [4]. As patient mortality is one of the most
important outcomes of CAP care, the development ofal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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facilitate hospital performance evaluations and aid inter-
hospital comparisons.
Several pneumonia mortality prediction models have
been developed for use in clinical settings, and the pri-
mary measure of model discrimination is the c-statistic.
The most reliable scoring systems currently for predict-
ing mortality in CAP patients are CURB-65 [5] (which
was modified from an earlier version developed by the
British Thoracic Society) and the pneumonia severity
index (PSI) [6]. However, CURB-65 does not take into
account patient comorbidities [7], and PSI includes fac-
tors that are not routinely examined, such as arterial pH.
In addition, it is possible that these models need further
improvement: a meta-analysis has reported the c-statistic
values for CURB-65 and PSI to be 0.80 and 0.81, respect-
ively [8]. The A-DROP scoring system, which is a modi-
fied version of CURB-65 developed by the Japanese
Respiratory Society, has a higher level of discrimination
than both CURB-65 and PSI, with a reported c-statistic of
0.85 [9].
Administrative databases comprising patient billing re-
cords have potential applications in the development of
useful risk-adjusted mortality prediction models. These
databases provide a wide variety of variables for analysis,
and the large quantity of real-world data accords a de-
gree of external validity to results. Rothberg et al. re-
ported that their risk-adjustment model for predicting
mortality in pneumonia patients based on administrative
data showed good discrimination (c-statistic: 0.85) [10].
Although administrative databases do not usually include
detailed clinical information, risk-adjustment models such
as CURB-65 or PSI do incorporate such information, and
are generally considered to be the gold standard in pneu-
monia mortality prediction. However, recent modifications
to a Japanese multicenter administrative claims database
have included the incorporation of clinical data according
to the A-DROP scoring system. This addition of clinical
data to the administrative database may support the devel-
opment of more accurate risk-adjustment models for
comparing hospital performances.
As patient charts contain details on standard predic-
tors of mortality (such as vital signs and clinical test re-
sults), the prediction of patient mortality using chart
review analyses are thought to be more accurate than
those based on administrative data. However, the collec-
tion of data from multiple institutions for chart review
analysis is labor-intensive and costly, thereby limiting its
applications in large-scale inter-hospital comparisons.
The purpose of our study was to develop and validate
a more accurate and practical risk-adjustment model to
predict 30-day in-hospital mortality in CAP patients
using factors available from a Japanese administrative
database.Methods
Data source
Patient-level data were obtained from the Quality Indicator/
Improvement Project (QIP)—a project that involves the
periodic collection of administrative claims data from
voluntary participant acute care hospitals in Japan. The
collected data are used in the subsequent analysis of
healthcare processes, patient outcomes, and disease man-
agement [11]. In 2014, there were 388 hospitals participat-
ing in the QIP. These hospitals varied in scale, region, and
healthcare provider type.
All participant hospitals provide data to the QIP ac-
cording to the Japanese Diagnosis Procedure Combin-
ation (DPC) system format, details of which have been
described elsewhere [12]. Briefly, the DPC system is a
case-mix classification system for reimbursements to
acute care hospitals in Japan under the public medical
insurance scheme.
DPC data contain discharge clinical summaries and ad-
ministrative claims information. Clinical summary data in-
clude hospital identifiers, patient demographics, discharge
statuses, major diagnoses, and comorbidities. Diseases are
identified through International Classification of Diseases,
10th Revision (ICD-10) codes. Clinical information to de-
termine pneumonia severity according to the A-DROP
system is also included. The administrative information
component includes the type, number, and date of clinical
procedures performed.
Study sample inclusion and exclusion criteria
The patient selection process is presented in Figure 1.
We selected inpatients who had been discharged (including
mortality cases) from the study hospitals between April 1,
2012 and September 30, 2013, and whose major diagnosis
for admission was pneumonia (ICD-10: J10–J18). Patients
were excluded if they were aged 14 years or younger, had
hospital-acquired pneumonia, repeated admission, long-
term hospitalization (>60 days), or had not been adminis-
tered an antibiotic within 2 days of admission. Patients
with missing data for all study variables except for body
mass index (BMI) were excluded from analysis. Patients
were also excluded if they had been admitted to a hospital
with a pneumonia case volume of only one patient during
the study period.
Statistical analysis
The primary endpoint was 30-day in-hospital mortality.
Patients were divided into a 30-day in-hospital mortality
group and a control (survival) group, and the baseline
patient characteristics of the 2 groups were compared
using Mann–Whitney U test or chi-squared test, as
appropriate.
Using 30-day in-hospital mortality as the dependent
variable, a hierarchical logistic regression model was
Figure 1 Patient selection from the Diagnostic Procedure Combination (DPC) database. amissing variable included blood urea nitrogen or
dehydration, respiratory state, orientation, blood pressure, C-reactive protein or extent of pneumonia infiltration, and immunodeficiency.
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the second level. We employed a random intercept
model with hospitals as random effects. We explored
the following candidate independent variables as fixed
effects: patient age, sex, BMI, vital signs, orientation dis-
turbance (assessed to be present if a patient’s Japan
Coma Scale [JCS] [13] score was 1 or more), extent of
pneumonia infiltration, dehydration, comorbidities, am-
bulance use, and life support procedures such as mech-
anical ventilator use, vasopressor use, and hemodialysis.
The attending physicians determined the extent of chest
X-ray infiltration (if any) and recorded the result on this
evaluation in the administrative database, detailing whether
the infiltration covered more than two-thirds of the lung.
Comorbidities included cancer (primary cancer and
metastatic cancer), liver disease, renal disease, congest-
ive heart failure, cerebrovascular disease, and immunedeficiency. The Dartmouth-Manitoba version of the
Charlson Comorbidity Index was used to identify comor-
bidities [14] (except immune deficiency) through corre-
sponding ICD-10 codes. The cut-off points to stratify
continuous variables such as age, BMI and C-reactive pro-
tein (CRP) were determined based on values reported in
the existing literature [15,16]. Discrimination of the logis-
tic regression model was evaluated using the c-statistic
[17], and internal validation was assessed using the boot-
strap method. We performed 1,000 bootstrap resamples
to calculate the odds ratios (ORs) of the predictors and c-
statistics of the models [18].
Strong predictors of mortality were selected from the
hierarchical logistic regression model for use in the de-
velopment of more refined models to predict 30-day in-
hospital mortality; the predictors were chosen to allow
accurate predictions of mortality with fewer independent
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an existing validated model, we also developed and ana-
lyzed a mortality prediction model based on the A-
DROP scoring system.
Finally, we created scoring systems in which each in-
dependent variable within a model was allocated a single
point, and we calculated the regression coefficients and
mortality rates in each cumulative score. We also com-
pared c-statistics between our scoring systems and the
A-DROP system using chi-squared tests. All statistical
analyses were performed using SPSS software, version 20
(SPSS Inc., Chicago, IL, USA) and STATA 12 statistical
software (STATA Corp, College Station, TX, USA).Ethical standard
The collection and analysis of DPC data from the QIP
hospitals were approved (Approval number: E-05) by the
Ethics Committee of Kyoto University Graduate School
of Medicine, and informed consent was waived. This study
complied with the Ethical Guidelines for Epidemiological
Research stipulated by the Japanese national government,
which include guidelines on protecting patient anonymity,
and all the necessary conditions were satisfied for in-
formed consent to be waived.Results
Patient characteristics
We analyzed 35,297 patients with CAP from 303 hospitals.
Table 1 presents the patient characteristics of the study
sample. The mean patient age was 78 years, and 20,667
(58.6%) patients were male. Hypoxemia (SpO2 < 90%) was
observed in 33.3% of the patients. Approximately one-
fourth of the patients had been hospitalized through emer-
gency admission via ambulance. The overall and 30-day
in-hospital mortality rates were 6.9% and 5.8%, respect-
ively, which were within the range reported in recent
pneumonia registries [19].Mortality prediction model for pneumonia
Table 2 shows the hierarchical logistic regression results
for 30-day in-hospital mortality after bootstrap resam-
pling. All predictors except the following were signifi-
cantly associated with increased ORs for mortality:
BMI ≥ 25 kg/m2, liver disease, renal disease, and cerebro-
vascular disease. Ordinal variables such as age, respira-
tory status, orientation, and blood pressure showed a
dose–response relationship with in-hospital mortality.
The c-statistic of the preliminary model was 0.896 (95%
confidence interval [CI]: 0890–0.903), while the c-
statistic of the model with bootstrap correction was
0.894 (95% CI: 0888–0.900), indicating a high level of
discrimination.Scoring systems for mortality prediction
Table 3 presents the results of 4 mortality prediction
models with the adjusted ORs of 30-day in-hospital mor-
tality. The models were developed using strong predic-
tors of mortality identified from the results of the initial
model presented in Table 2. These 4 models included an
A-DROP model and 3 newly developed models (desig-
nated Models 0, 1, and 2). The A-DROP model was de-
veloped using variables of the existing A-DROP scoring
system. In contrast to the A-DROP model, Model 0 and
Model 1 excluded sex as a variable, and the cut-off ages
were changed to 65 years and 80 years, respectively.
Model 2 utilized the same predictors as Model 1, with
the following 3 additional binary variables: CRP ≥
200 mg/L or extent of consolidation on chest X-ray ≥ 2/3,
use of mechanical ventilator/vasopressors, and presence of
cancer. There were only low correlations observed be-
tween each of the variables in Table 3 (All Pearson’s coeffi-
cients were less than 0.22, P < 0.01). The c-statistics of
Model 1 and Model 2 were 0.854 (95% CI: 0846–0.862)
and 0.874 (95% CI: 0867–0.882), respectively.
Table 4 presents the regression coefficients and 30-day
in-hospital mortality rates for each score category of the
A-DROP model, Model 1, and Model 2. In each model,
the mortality rates increased together with increasing
scores. The c-statistics for the scoring systems of the
A-DROP model, Model 1, and Model 2 were 0.851
(95% CI: 0844–0.859), 0.850 (95% CI: 0842–0.858), and
0.871 (95% CI: 0864–0.879), respectively. Model 2 had
a significantly higher c-statistic than the A-DROP model
(P < 0.001), while there was no statistical difference be-
tween the A-DROP model and Model 1 (P = 0.464).
Discussion
In this study, we developed and internally validated risk-
adjustment models and scoring systems for predicting in-
hospital mortality in CAP patients using Japanese DPC
data. In an analysis of 35,397 patients from 303 hospitals,
our hierarchical logistic regression model demonstrated
strong predictive power for CAP mortality with a c-
statistic of 0.894 after bootstrap correction. This predictive
power was comparable with existing mortality prediction
models, regardless of whether they were based on chart
reviews or administrative data [20]. In our model, we in-
cluded unique variables not used in existing models, such
as BMI, life support procedures, CRP, size of infiltration in
chest X–ray, and ambulance use.
BMI below 18.5 kg/m2 was significantly associated
with increased ORs for mortality relative to the BMI
range of 18.5–24.9 kg/m2; in contrast, BMI of 25 kg/m2
or more was significantly associated with decreased mor-
tality. This finding was consistent with the results of re-
cent studies [15,21]. However, a substantial number of
cases in our sample had missing BMI data (n = 4,698),





Number of hospitals N = 303
Patient characteristics n = 35,297 n = 33,256 n = 2,041 P
Median age, year (IQR) 78 (68–86) 78 (67–85) 85 (79–90) < 0.001a
Male, no. (%) 20,667 (58.6) 19,359 (58.2) 1308 (64.1) < 0.001b
Median BMI, kg/m2 (IQR) 20.7 (18.2-23.5) 20.8 (18.3-23.6) 19.1 (16.6-21.7) < 0.001a
BUN ≥7.5 mmol/L or Dehydration, no. (%) 12,623 (35.8) 11,183 (33.6) 1,440 (70.6) < 0.001b
SpO2 < 90%, no. (%) 11,753 (33.3) 10,423 (30.8) 1,510 (74.0) < 0.001
b
Orientation disturbance, no. (%) 6,116 (17.3) 5,189 (15.6) 927 (45.4) < 0.001b
Systolic BP ≤90 mmHg, no. (%) 2,038 (5.8) 1,507 (4.5) 531 (26.0) < 0.001b
CRP 200 mg/L or extent of consolidation on chest
X-ray ≥2/3 of one lung, no. (%)
6,333 (17.9) 5,423 (16.3) 910 (44.6) < 0.001b
Comorbidities, no. (%)
Cancer 4,154 (11.8) 3,800 (11.4) 354 (17.3) < 0.001b
Liver disease 242 (0.7) 229 (0.7) 13 (0.6) 0.784b
Renal disease 1,558 (4.4) 1,407 (4.2) 151 (7.4) < 0.001b
Congestive heart failure 5,435 (15.4) 4,877 (14.7) 558 (27.3) < 0.001b
Cerebrovascular disease 3,002 (8.5) 2,819 (8.5) 183 (9.0) 0.442b
Immune deficiency 2,404 (6.8) 2,167 (6.5) 237 (11.6) < 0.001b
Emergency admission via ambulance, no. (%) 9,418 (26.7) 8,320 (25.0) 1,098 (53.8) < 0.001b
Life support procedure, no. (%)
Mechanical ventilatorc 795 (2.3) 514 (1.5) 281 (13.8) < 0.001b
Vasopressorc 552 (1.6) 305 (0.9) 1247 (12.1) < 0.001b
Hemodialysisc 396 (1.1) 361 (1.1) 35 (1.7) 0.003b
aP values by Mann–Whitney U test. bP values by chi-squared test.
cVentilator and vasopressor treatments were started within 2 days of admission. Hemodialysis was started within 3 days of admission.
Abbreviations: IQR, interquartile range; BMI, body mass index; BUN, blood urea nitrogen; SpO2, pulse oximetry saturation; BP, blood pressure; CRP, C-reactive protein.
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ated with increased mortality than any other BMI range.
The reason for the missing data and its impact on mor-
tality prediction should be addressed in the future.
The use of mechanical ventilation or vasopressors
was strongly associated with increased mortality, al-
though the proportion of patients in our sample who
had undergone these procedures was relatively small.
Ewig et al. [22] reported that the modified American
Thoracic Society rule, which includes the requirement
for mechanical ventilation or septic shock as a param-
eter, had excellent predictive power for pneumonia se-
verity. In the practical clinical setting, however, life
support procedures are not always conducted, espe-
cially in very elderly or terminal patients in consider-
ation for their quality of life. If we were to analyze the
requirement for mechanical ventilation or vasopressors
in place of the use of these treatments as a variable for
mortality prediction, the predictive power of the former
may be higher than that of the latter due to a higher
proportion of patients who qualify for these proceduresbut do not actually receive them. Therefore, the re-
quirement for mechanical ventilation or vasopressors
may be preferable as a variable than the actual use of
these procedures.
Our use of a combination variable that integrated the
parameters of CRP ≥ 200 mg/l and chest X-ray infiltra-
tions covering at least two-thirds of one lung is unique
among the international standard scoring systems. The
individual associations of increased mortality with in-
creased CRP level alone or infiltration on chest X-ray
alone have previously been reported [16,23,24]. In our
study, the combination variable showed a similar inci-
dence and OR for mortality as orientation disturbance.
We believe that the severity scoring systems presented
here can be used by healthcare organizations to evaluate
healthcare and offer better quality of care. With an em-
phasis on practical usability, we sought to develop a
scoring system with a high level of discrimination that
utilizes a small number of variables. To this end, we de-
veloped and validated 2 scoring systems that are modi-
fied versions of the A-DROP scoring system.





Male 1.29 (1.15-1.45) < 0.001
BMI (reference, ≥18.5 and <25 kg/ m2) reference
Missing BMI dataa 1.93 (1.66-2.24) < 0.001
<18.5 kg/m2 1.55 (1.36-1.77) < 0.001
≥25 kg/m2 0.79 (0.63-0.97) 0.028
Age (reference, 15–64 y) reference
65–74 y 2.08 (1.55-2.79) < 0.001
75–84 y 3.26 (2.50-4.25) < 0.001
≥85 y 5.25 (3.99-6.91) < 0.001
BUN ≥7.5 mmol/L or Dehydration 1.88 (1.67-2.12) < 0.001
SpO2 (reference >90%, room air) reference
FiO2 < 35%
b (without Ventilator) 2.40 (2.09-2.75) < 0.001
FiO2 ≥ 35%
b (without Ventilator) 6.63 (5.61-7.82) < 0.001
Ventilatorc 7.55 (6.00-9.52) < 0.001
Orientation (reference JCS 0) reference
JCS 1-3 1.65 (1.43-1.90) < 0.001
JCS 10-30 2.86 (2.30-3.55) < 0.001
JCS 100-300 4.21 (3.20-5.53) < 0.001
Systolic BP (reference > 90 mmHg) reference
≤90 mmHg (without Vasopressor) 2.96 (2.51-3.49) < 0.001
Vasopressorc 4.24 (3.27-5.48) < 0.001
CRP 200 mg/L or extent of consolidation
on chest X-ray ≥2/3 of one lung
2.27 (2.00-2.58) < 0.001
Comorbidities
Cancer 2.25 (1.93-2.63) < 0.001
Liver disease 1.38 (0.76-2.51) 0.286
Kidney (reference free) reference
Renal disease (without Hemodialysis) 1.20 (0.94-1.55) 0.149
Hemodialysisc 1.55 (0.95-2.54) 0.080
Congestive heart failure 1.43 (1.26-1.61) < 0.001
Cerebrovascular disease 0.84 (0.68-1.02) 0.081
Immune deficiency 1.45 (1.20-1.76) < 0.001
Emergency admission via ambulance 1.50 (1.33-1.69) < 0.001
c-statistic 0.894 (0.888-0.900) < 0.001
Abbreviations: CI, confidence interval; BMI, body mass index; BUN, blood urea
nitrogen; SpO2, pulse oximetry saturation; FiO2, fraction of inspired oxygen;
JCS, Japan Coma Scale; BP, blood pressure; CRP, C-reactive protein.
aBMI data missing: BMI data were missing in 4,698/35,297 pneumonia patients.
bFiO2 < 35% and ≥35%: fraction of inspired oxygen (<35% and ≥35%, respectively)
required to maintain SpO2 > 90%.
cVentilator and vasopressor treatments were started within 2 days of
admission. Hemodialysis was started within 3 days of admission.
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tem was not statistically different from that of the A-
DROP system, even though the former did not include
patient sex as a variable. We posit that the lack ofdifference between the discriminatory powers of the 2
systems was due to a weak association between sex and
mortality, as well as the superior predictive power of
using a cut-off age of 80 years. The median age of our
study population was 78 years, and a cut-off age of
80 years resulted in a more equal distribution of the sam-
ple. CURB-65, which uses a cut-off age of 65 years, was
established in 2000 using a study population with a mean
age of 64 years [5]. This underlines the importance of con-
sidering the appropriate cut-off age for the scoring system
based on the age composition of the target population.
The Model 2 scoring system had better discrimination
than the A-DROP system. The use of mechanical ventila-
tion or vasopressors remained strongly associated with
mortality even after adjusting for hypoxemia (SPO2 < 90%)
and hypotension (Systolic BP < 90 mmHg). Therefore, the
use of mechanical ventilation or vasopressors was given a
weight of 1 point in our severity score, independent of
respiratory failure or hypotension. In addition, Model 2
showed that cancer was a strong predictor for mortality
among the comorbidities. Fine et al. have also acknowl-
edged the strong association between cancer and mortality
by giving the presence of cancer the highest score of all
comorbidities in the PSI [25].
This study showed that our models were able to accur-
ately predict mortality in CAP patients using only adminis-
trative data from within 2 days of hospital admission. Our
risk-adjusted models may have applications in conducting
more precise hospital performance evaluations and inter-
hospital comparisons. Additionally, we hope these models
may also have applications in developing more appropriate
payment systems in the future that are able to take the dif-
ferent levels of pneumonia severity into account.
Limitations
There are several limitations to this study. First, our sam-
ples may not be representative of all CAP cases because we
did not include patients whose major diagnosis was either
sepsis or respiratory failure with a secondary diagnosis of
pneumonia. The inclusion of these patients may raise the
overall or 30-day in-hospital mortality rates above those
observed in our sample [26]. Furthermore, we did not ex-
clude patients with diagnoses of interstitial pneumonia or
exacerbation of chronic obstructive pulmonary disease imi-
tating CAP. The difference in sampling range for pneumo-
nia patients could therefore introduce misclassification bias
to the study and potentially confound our results.
Second, the models developed in this study were only in-
ternally validated, and we did not conduct external valid-
ation using other data sets. However, we did use a large
dataset of 303 hospitals with a variety of characteristics,
which may improve the generalizability of the results. Fur-
thermore, it is possible that a split-group validation may be
more appropriate than the bootstrap method used here
Table 3 Multivariable predictors of 30-day in-hospital mortality in each scoring system
Adjusted odds ratio (95% CI)
A-DROPa model Model 0 Model 1 Model 2
Number of predictors 5 5 5 8
Age ≥65 y 3.35 (2.15-2.97)
Age ≥70 y (male) or Age≥ 75 y (female) 2.52 (2.15-2.97)
Age ≥80 y 2.00 (1.79-2.23) 2.43 (2.17-2.73)
BUN ≥7.5 mmol/L or Dehydration 2.59 (2.32-2.88) 2.61 (2.32-2.88) 2.59 (2.32-2.88) 2.15 (1.93-2.41)
SpO2 ≤ 90% 4.29 (3.84-4.79) 4.28 (3.83-4.79) 4.36 (3.90-4.87) 3.47 (3.09-3.89)
Orientation disturbance 2.70 (2.42-3.00) 2.77 (2.49-3.08) 2.62 (2.35-2.91) 2.46 (2.20-2.75)
Systolic BP ≤90 mmHg 4.12 (3.62-4.69) 4.08 (3.58-4.64) 4.18 (3.67-4.76) 3.23 (2.82-3.70)
CRP 200 mg/L or extent of consolidation on chest
X-ray ≥2/3 of one lung
2.41 (2.16-2.69)
Mechanical ventilator or Vasopressor 4.18 (3.56-4.92)
Cancer 2.07 (1.81-2.38)
c-statistic 0.853 (0.845-0.861) 0.852 (0.844-0.860) 0.854 (0.846-0.862) 0.874 (0.867‐0.882)
Abbreviations: CI, confidence interval; BUN, blood urea nitrogen; SpO2, pulse oximetry saturation; BP, blood pressure; CRP, C-reactive protein.
aA-DROP: A, Age ≥70 y (male), ≥75 y (female); D, BUN ≥7.5 mmol/L; R, SPO2 < 90%; O, Orientation disturbance; P, Systolic BP <90 mmHg.
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have a degree of overlap due to the large size of the original
cohort. More studies should be conduct to further validate
our models before they can be used in practical settings.
Third, the database used in this study still lacked cer-
tain clinical variables that may improve our ability to
predict mortality. Arterial pH, the level of serum so-
dium, serum albumin, and the presence of plural effu-
sions have been reported to be strong predictors of
mortality [25,27], but were unavailable in our data.
Fourth, there are only 4 coding slots for comorbidities
in the Japanese DPC database. Therefore, the incidence
of comorbidities (such as cancer) in pneumonia cases
identified in this study may be lower than actual inci-
dences. Improving the coding system to allow more co-
morbidities to be recorded may enhance the quality of
research based on these data.Table 4 Adjusted logarithmic odds ratios and 30-day mortalit
A-DROPa model
LOR (95% CI) Deathb/Total (%) LOR (95% CI)
Score 0 reference 17/6,877 (0.2) reference
Score 1 1.80 (1.25-2.34) 156/10,543 (1.5) 1.62 (1.30-1.94)
Score 2 2.96 (2.43-3.49) 434/9,279 (4.5) 2.65 (2.35-2.96)
Score 3 4.13 (3.61-4.66) 707/4,967 (12.5) 3.75 (3.45-4.06)
Score 4 5.14 (4.61-5.68) 522/1,445 (26.5) 4.67 (4.36-4.98)
Score 5 6.59 (6.01-7.16) 205/350 (58.6) 6.12 (5.74-6.50)
Score ≥6
c-statistic 0.851 (0.844-0.859) 0.85
Abbreviations: LOR, logarithmic odds ratio; CI, confidence interval.
aA-DROP: A, Age ≥ 70 (male), ≥ 75 (female); D, BUN ≥ 7.5 mmol/L; R, SPO2 ≤ 90%; O,
bDeath, 30-day in-hospital mortality.Fifth, our study did not include a direct comparison of
our models with the CURB-65 scoring system, which
may be the most common method used to predict mor-
tality in pneumonia; we were unable to calculate CURB-
65 scores as our database did not include respiratory
rate and blood urea nitrogen values as continuous vari-
ables, which are required parameters. However, apart
from these two variables, our Model 0 was very similar
to the CURB-65 scoring system.
Sixth, mortality in elderly patients or patients with ter-
minal cancer can be affected by the degree of aggressive
treatments that they receive. Predictors in our models
may be confounded by this factor, as we could not ac-
quire information regarding the degree of aggressive
treatments received at the patient level in this study.
Finally, our data were obtained from acute care hospi-
tals that voluntarily participate in the QIP. Therefore,y in each score
Model 1 Model 2
Deathb/Total (%) LOR (95% CI) Deathb/Total (%)
44/10,059 (0.4) reference 21/7,831 (0.3)
220/10,148 (2.1) 1.59 (1.10-2.08) 125/9,687 (1.3)
466/8,299 (5.6) 2.68 (2.22-3.14) 306/8,360 (3.7)
677/4,945 (14.6) 3.60 (3.14-4.05) 460/5,477 (8.4)
473/1,658 (28.5) 4.63 (4.17-5.09) 502/2,558 (19.6)
161/268 (60.1) 5.56 (5.09-6.03) 393/1,054 (37.3)
6.82 (6.31-7.32) 234/360 (65.0)
0 (0.842-0.858) 0.871 (0.864-0.879)
Orientation disturbance; P, Systolic BP ≤ 90 mmHg.
Uematsu et al. BMC Pulmonary Medicine 2014, 14:203 Page 8 of 8
http://www.biomedcentral.com/1471-2466/14/203there may be a degree of sampling bias that weakens the
generalizability of our findings to chronic care facilities.
Conclusions
In this study of 35,297 patients with CAP in Japan, we de-
veloped and internally validated risk-adjustment models
and scoring systems for predicting in-hospital mortality
using Japanese administrative data complemented with
clinical data concerning pneumonia severity. Our models
and scoring systems had superior discriminatory power
over existing models, and may improve risk adjustments
for inter-hospital comparisons and more accurate predic-
tion of mortality in CAP patients.
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